.
MergerLinks Header Logo

Announced

Completed

A consortium of investors led a $270m funding round in Yaoshibang.

Financials

Edit Data
Transaction Value£191m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

Private Equity

Minority

China

pharmaceutical

Venture Capital

Domestic

Pharmaceuticals

Friendly

Completed

Private

Acquisition

Synopsis

Edit

A consortium of investors led a $270m funding round in Yaoshibang, a Chinese pharmaceutical trading platform. The consortium consisted of Zhejiang Pearl River Investment Management, Baidu, Green Pine Capital Partners and Guangzhou City Construction Investment. Following the investment, Yaoshibang will look to upgrade digital sales, marketing systems, and its data-sharing platform.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US